Radiotherapy & Oncology
Volume 90, Issue 1 , Pages 36-42, January 2009

Clinical implementation of a new HDR brachytherapy device for partial breast irradiation

Department of Radiation Oncology, UC San Diego, La Jolla, USA

Received 26 February 2008; received in revised form 16 September 2008; accepted 19 September 2008. published online 27 October 2008.

Abstract 

Purpose

To present the clinical implementation of a new HDR device for partial breast irradiation, the Strut-Adjusted Volume Implant (SAVI), at the University of California, San Diego.

Methods and materials

The SAVI device has multiple peripheral struts that can be differentially loaded with the HDR source. Planning criteria used for evaluation of the treatment plans included the following dose volume histogram (DVH) criteria: V90 >90%, V150 <50cc and V200 <20cc.

Results

SAVI has been used on 20 patients to date at UC San Diego. In each case, the dose was modulated according to patient-specific anatomy to cover the tumor bed, while sparing normal tissues. The dosimetric data show that we can achieve greater than 90% coverage with respect to V90 (median of 95.3%) and also keep a low V150 and V200 dose at 24.5 and 11.2cc, respectively. Complete treatment can be done within a 30-min time slot, which includes implant verification, setup, and irradiation time as well as wound dressing.

Conclusion

SAVI has been implemented at UC San Diego for accelerated partial breast irradiation with excellent tumor bed conformance and minimal normal tissue exposure. Patient positioning is the key to identifying any inter-fraction device motion. Device asymmetry or tissue conformance has been shown to resolve itself 24h after the device implantation. The device can be implemented into an existing HDR program with minimal effort.

Keywords: Breast cancer, Brachytherapy, Partial breast irradiation, Breast-conserving therapy, SAVI

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-8140(08)00515-X

doi:10.1016/j.radonc.2008.09.024

Radiotherapy & Oncology
Volume 90, Issue 1 , Pages 36-42, January 2009